Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-12-035354)

Filing Details

Accession Number:: 0001140361-12-035354
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-06 20:12:48
Reporting Period:: 2012-08-06

Filing Date:: 2012-08-06
Accepted Time:: 2012-08-06 20:12:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1207604	Alan Lewis	C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-06	30,000	$14.21	55,900	No	4	M	Direct
Common Stock	Disposition	2012-08-06	40,000	$37.57	15,900	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2012-08-06	30,000	$0.00	30,000	$14.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
83,500	2006-09-28	2016-06-27	No	4	M	Direct

Footnotes

The range of sales prices received was $37.22 to $37.98. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Options vest 1/4th each on September 28, 2006, December 28, 2006, March 28, 2007 and June 28, 2007.